image
Verona Pharma plc VRNA
Healthcare - Biotechnology - NASDAQ - GB
Watchlist
$ 35.66
0.82 %
$ 2.92 B
Market Cap
-18.67
P/E
BALANCE SHEET
308 M ASSETS
18.75%
Growth Rates
1Year 18.75%
3Years 14.70%
5Years 26.74%
7Years 27.28%
10Years 53.59%
58.8 M LIABILITIES
102.89%
Growth Rates
1Year 102.89%
3Years 44.87%
5Years 32.56%
7Years 22.27%
10Years 53.56%
249 M EQUITY
8.16%
Growth Rates
1Year 8.16%
3Years 10.48%
5Years 25.57%
7Years 28.74%
10Years 53.60%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Verona Pharma plc
image
Current Assets 290 M
Cash & Short-Term Investments 272 M
Receivables 11 M
Other Current Assets 6.98 M
Non-Current Assets 18.4 M
Long-Term Investments 15 M
PP&E 2.87 M
Other Non-Current Assets 545 K
Current Liabilities 8.69 M
Accounts Payable 3.49 M
Short-Term Debt 1.18 M
Other Current Liabilities 4.02 M
Non-Current Liabilities 50.1 M
Long-Term Debt 50.1 M
Other Non-Current Liabilities 0

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005
ASSETS
Cash & Cash Equivalents 271.8 227.8 148.4 188.0 30.1 25.1 42.5 49.1 5.2 15.5 1.0 1.6 3.9 3.1 4.6 3.6 2.5 2.1 1.7
Short Term Investments 0 0 0 0 10.3 57.0 66.0 0 0 0 0 0 0 0 0 0 0 2.5 0
Receivables 11.0 9.3 15.6 8.3 0 7.1 0 0 0 0 0 0 0 0 0 0 0.5 0 0
Inventory 1 2.5 4.0 4.5 3.5 0.000001 0 0 0 0 0 0 (0.1) (0.1) (0.6) 99.6 K (0.5) 0 3.44 K
Other Current Assets 7.0 5.9 6.1 6.3 13.5 8.5 9.2 5.0 2.0 2.4 0.2 0.3 0.1 0.1 0.6 99.6 K 0.5 0.1 15.5 K
Total Current Assets 289.7 243.0 170.1 202.5 53.7 90.9 117.7 54.1 8.3 17.5 1.4 1.9 4.1 3.2 5.2 3.7 3.0 4.7 1.7
PP&E 2.9 0.9 1.0 1.2 1.3 26.6 K 21.6 K 17.1 K 20.5 K 34 K 45.6 K 63.8 K 9.32 K 23.2 K 29.1 K 20.5 K 31.7 K 33.3 K 0
Intangible Assets 0 0 0 0 3.6 2.7 2.7 2.3 0.5 0.6 0.3 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0
Goodwill 0.5 0.5 0.5 0.5 0.6 0.6 0.6 0.5 2.2 2.3 2.4 2.4 2.3 2.3 2.4 2.2 2.9 2.9 0
Long Term Investments 15.0 15.0 15.0 0 0 0 0 0 0 0 0 0 0.446 0.0409 1.01 0.594 0.389 0.000001 0
Other Long Term Assets 0 15.1 15.1 0 0 0 1 0 0 0 1 0 (3.9) (3.1) (4.6) (3.6) (2.5) (2.1) 0
Other Assets 0 0 0 0 1 1 0 0 1 1 1 0 1 1 0 1 1 1 (1.7)
Total Assets 308.1 259.5 186.6 204.2 59.2 94.2 121.0 56.9 11.0 20.4 4.2 4.5 6.5 5.6 7.7 6.0 6.0 7.8 1.7
LIABILITIES
Accounts Payable 3.5 2.9 10.0 0.2 1.9 3.6 1.2 0.7 1.9 0.6 0.5 0.2 0.1 0.2 0.2 71.8 K 0.2 66.6 K 20.6 K
Short Term Debt 1.2 0.7 0.6 1.6 0.6 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Liabilities 4.0 15.2 22.6 12.4 10.1 9.4 10.2 12.5 0.8 0.2 0.3 0.1 0.1 98.8 K 0.3 51.3 K 0.1 62.7 K 0
Total Current Liabilities 8.7 19.0 33.4 14.2 12.6 13.0 11.6 13.4 2.7 0.8 0.8 0.3 0.2 0.3 0.5 0.1 0.3 0.1 20.6 K
Long Term Debt 50.1 10.0 5.2 5.1 0.5 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Deferred Tax Income 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Liabilities 0 0 0 0 0.2 1.3 1.2 1.0 0 0 0 0 0 0 0 0 0 0 0
Total Liabilities 58.8 29.0 38.6 19.4 14.8 14.4 13.0 14.4 2.7 0.8 0.8 0.3 0.2 0.3 0.5 0.1 0.3 0.1 20.6 K
EQUITY
Common Stock 42.8 40.5 31.9 31.8 6.9 6.7 7.1 3.2 1.5 1.6 0.6 0.5 0.4 0.4 0.4 0.3 0.3 0.3 86 K
Retained Earnings (388.4) (333.1) (263.7) (207.1) (131.9) (87.7) (66.6) (35.4) (34.2) (24.5) (21.7) (17.2) (12.7) (10.1) (7.5) (4.6) (3.6) (1.1) 44.7 K
Other Accumulative Comprehensive Income/Loss (4.6) (4.6) (4.6) (4.6) 11.4 0 0 3.9 K (0.1) (0.1) (0.1) (0.1) 0.8 0.6 0.6 0.5 0.8 1.96 K 0
Total Equity 249.3 230.5 148.0 184.9 44.4 79.9 108.0 42.5 8.3 19.6 3.4 4.2 6.3 5.3 7.2 5.8 5.7 7.6 1.7
Total Liabilities and Equity 308.1 259.5 186.6 204.2 59.2 94.2 121.0 56.9 11.0 20.4 4.2 4.5 6.5 5.6 7.7 6.0 6.0 7.8 1.7
SHARES OUTSTANDING
Common Shares Outstanding 79.3 66.1 59.1 32.9 13.2 131.4 109.7 2 093.7 1 262.4 1 083.4 427.0 383.3 304.3 298.5 269.4 261.4 180.5 96.6 55.9